Recently, the frontier drug INT230-6 showed good tumour killing effects in the treatment of soft tissue sarcoma in the single arm phase 1/2 open-label clinical trial IT-01 (NCT03058289), and the drug showed good responses whether injected inside the tumour alone or in combination with the CTLA-4 immune checkpoint inhibitor ipilimumab.
Apparatus
-
-
Apparatus
Major Breakthrough In 27 Years! This Cancer Vaccine Has Kept Deadly Brain Cancer Patients Alive For Over 8 Years!
A dendritic cell vaccine has shown excellent results in the treatment of glioblastoma, significantly extending the survival of patients with a good safety profile, according to new data from a global clinical trial. To date, patients who have benefited for the longest time have survived for more than eight years.
-
HBM1020 is the world's first anti-B7H7 monoclonal antibody to be formally approved for clinical phase.
-
Apparatus
Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery
The collaboration aims to improve the efficiency of the drug discovery pipeline by leveraging industry-leading capabilities to identify genetic variants that cause human disease.
-
SKB264 is currently in Phase II and Phase III clinical trials as a single agent/combination for multiple tumour types.
-
Apparatus
The "hand speed" is extremely fast, and scientists create a DNA robot arm that can move at a high speed
DNA nano robot system is one of the nano machines, and has been continuously developed in recent years. In recent years, in the journal Science, we saw another "feat" realized by DNA nano robot - researchers used electric field to accelerate the movement speed of DNA robot system.
-
Apparatus
New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely!
The US FDA has approved a new leukaemia drug, Olutasidenib, which has been shown to be effective and has a controlled safety profile, resulting in the complete disappearance of cancer cells in 35% of patients enrolled, with efficacy lasting up to 25.9 months.
-
Carvykti gains new ground and competes with its "predecessor"!
-
Recently, Nassim Annabi, an assistant professor of Northeastern University in the United States, and other researchers from the University of Sydney in Australia jointly developed an advanced surgical glue MeTro. When using, the glue directly enters the wound and is solidified and sealed within 60 seconds. Naxim said, "The advantage of MeTro formula is that once it touches the organ, it will appear as gel instantly and will not slip."
-
Apparatus
New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide
Misconceptions about how to treat a sore throat are fuelling the overuse of antibiotics, according to STAR research.